RNA replicons provide the genetic instructions to the body’s own cells to produce ample amounts of protein and unleash an immune response. Replicons carry the RNA code for a self-replication engine as well as multiple antigens that signal for immune response. RNA replicons can trigger antigen expression within host cells, increase T-cell response (including when the host is already infected), and lower dose requirements compared to traditional RNA-based vaccine and therapeutic approaches.
March 11, 2018
Arcturus Therapeutics Announces Extraordinary General Meeting of Shareholders
March 9, 2018
Arcturus Therapeutics to Present at Bio Europe on March 13th
March 5, 2018
Arcturus Therapeutics Calls on Proposed Director Nominees to Respond to Constructive Board Outreach